BDNF and Cognitive impairment: Given research demonstrating the association between BDNF and relevant biochemical/physiological pathways related to cognitive function, combined clinical studies demonstrating associations of circulating BDNF levels with the onset of cancer-related cognitive impairments, utilization of BDNF as an informative biomarker in clinical care seems like a logical next step.